59 related articles for article (PubMed ID: 8691836)
1. Occurrence of monocytoid B lymphocytes in lymph nodes of patients treated by chemotherapy.
Ohnishi A; Ohsawa M; Yasunaga Y; Ijuin N; Sawada M; Yamamoto S; Aozasa K
J Surg Oncol; 1996 Aug; 62(4):245-8. PubMed ID: 8691836
[TBL] [Abstract][Full Text] [Related]
2. The occurrence of monocytoid B-lymphocytes in the spleen in gastric cancer.
Aozasa K; Ohsawa M; Horiuchi K; Mishima K; Kawano K; Ito N
Mod Pathol; 1993 Nov; 6(6):717-20. PubMed ID: 8302814
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of monocytoid B-lymphocytes in Hodgkin's disease.
Ohsawa M; Kanno H; Naka N; Aozasa K
Mod Pathol; 1994 Jun; 7(5):540-3. PubMed ID: 7937719
[TBL] [Abstract][Full Text] [Related]
4. Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2.
Meneses A; Verastegui E; Barrera JL; de la Garza J; Hadden JW
Int Immunopharmacol; 2003 Aug; 3(8):1083-91. PubMed ID: 12860165
[TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY
Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
7. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
[TBL] [Abstract][Full Text] [Related]
9. Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy.
Vekemans M; Robinson J; Georgala A; Heymans C; Muanza F; Paesmans M; Klastersky J; Barette M; Meuleman N; Huet F; Calandra T; Costantini S; Ferrant A; Mathissen F; Axelsen M; Marchetti O; Aoun M
Clin Infect Dis; 2007 Jun; 44(12):1593-601. PubMed ID: 17516403
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
[TBL] [Abstract][Full Text] [Related]
11. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
12. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
13. [The quality of life after chemotherapy in advanced non-small cell lung cancer patients].
SÅ‚owik-Gabryelska A; Szczepanik A; Kalicka A
Pol Merkur Lekarski; 1999 Jan; 6(31):18-22. PubMed ID: 10344148
[TBL] [Abstract][Full Text] [Related]
14. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.
Fisher ER; Wang J; Bryant J; Fisher B; Mamounas E; Wolmark N
Cancer; 2002 Aug; 95(4):681-95. PubMed ID: 12209710
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cell cycle-related proteins in mediastinal lymph nodes of patients with N2-NSCLC obtained by EBUS-TBNA: relevance to chemotherapy response.
Mohamed S; Yasufuku K; Nakajima T; Hiroshima K; Kubo R; Iyoda A; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Farouk A; Fujisawa T
Thorax; 2008 Jul; 63(7):642-7. PubMed ID: 18390633
[TBL] [Abstract][Full Text] [Related]
16. [Drug concentration in axillary lymph nodes of patients with breast cancer after lymphatic chemotherapy].
Chen JH; Yang YM; Li KZ; Ling R; Yao Q; Yang H
Ai Zheng; 2005 Apr; 24(4):494-7. PubMed ID: 15820077
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.
Nieuwenhuijzen JA; Bex A; Meinhardt W; Kerst JM; Schornagel JH; VAN Tinteren H; Horenblas S
J Urol; 2005 Jul; 174(1):80-5. PubMed ID: 15947583
[TBL] [Abstract][Full Text] [Related]
18. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Nakamori M; Iwahashi M; Nakamura M; Yamaue H
J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
[TBL] [Abstract][Full Text] [Related]
19. Is intraoperative frozen section analysis of pelvic lymph nodes accurate after neoadjuvant chemotherapy in patients with cervical cancer?
Bader AA; Winter R; Moinfar F; Petru E; Pristauz G; Scholz HS; Haas J; Tamussino KF
Gynecol Oncol; 2006 Oct; 103(1):106-12. PubMed ID: 16564076
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]